Perspective Therapeutics Introduces Pre-Targeting Theranostic Technology Platform

Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...

Related Keywords

United States ,American ,Jacobl Houghton ,Michaelk Schultz ,Thijs Spoor ,Vilmaij Jallinoja ,Jacob Houghton ,Department Of Energy ,Journal Of Nuclear Medicine ,National Institutes Of Health ,National Cancer Institute ,Fastrack Small Business Innovation Research ,Perspective Therapeutics Inc ,Radiology At Stony Brook University ,Stony Brook University ,World Molecular Imaging Congress ,Exchange Commission ,World Wide Exclusive License ,Novel Platform ,Enhance Radionuclide ,National Institutes ,Chief Executive Officer ,Chief Science Officer ,Adamantane Host ,Guest Pair ,Xenograft Models ,Stony Brook ,Assistant Professor ,Perspective Therapeutics ,Transition Report ,Quarterly Report ,